Nanalysis Scientific Corp Stock Fundamentals
NSCIF Stock | USD 0.24 0.03 11.11% |
Nanalysis Scientific Corp fundamentals help investors to digest information that contributes to Nanalysis Scientific's financial success or failures. It also enables traders to predict the movement of Nanalysis OTC Stock. The fundamental analysis module provides a way to measure Nanalysis Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanalysis Scientific otc stock.
Nanalysis |
Nanalysis Scientific Corp OTC Stock Return On Equity Analysis
Nanalysis Scientific's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nanalysis Scientific Return On Equity | -0.2 |
Most of Nanalysis Scientific's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanalysis Scientific Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Nanalysis Scientific Corp has a Return On Equity of -0.197. This is 98.36% lower than that of the Technology sector and 128.14% lower than that of the Scientific & Technical Instruments industry. The return on equity for all United States stocks is 36.45% lower than that of the firm.
Nanalysis Scientific Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanalysis Scientific's current stock value. Our valuation model uses many indicators to compare Nanalysis Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanalysis Scientific competition to find correlations between indicators driving Nanalysis Scientific's intrinsic value. More Info.Nanalysis Scientific Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nanalysis Scientific's earnings, one of the primary drivers of an investment's value.Nanalysis Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanalysis Scientific's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nanalysis Scientific could also be used in its relative valuation, which is a method of valuing Nanalysis Scientific by comparing valuation metrics of similar companies.Nanalysis Scientific is currently under evaluation in return on equity category among its peers.
Nanalysis Fundamentals
Return On Equity | -0.2 | |||
Return On Asset | -0.0726 | |||
Profit Margin | (0.30) % | |||
Operating Margin | (0.28) % | |||
Current Valuation | 52.82 M | |||
Shares Outstanding | 94.22 M | |||
Shares Owned By Insiders | 7.37 % | |||
Shares Owned By Institutions | 0.09 % | |||
Price To Book | 1.91 X | |||
Price To Sales | 2.30 X | |||
Revenue | 16.04 M | |||
Gross Profit | 10.24 M | |||
EBITDA | 1.38 M | |||
Net Income | (1.77 M) | |||
Cash And Equivalents | 12.28 M | |||
Cash Per Share | 0.13 X | |||
Total Debt | 2.75 M | |||
Debt To Equity | 0.16 % | |||
Current Ratio | 1.94 X | |||
Book Value Per Share | 0.39 X | |||
Cash Flow From Operations | (1.2 M) | |||
Earnings Per Share | (0.03) X | |||
Number Of Employees | 107 | |||
Beta | 0.98 | |||
Market Capitalization | 47.47 M | |||
Total Asset | 37.79 M | |||
Z Score | 10.2 | |||
Net Asset | 37.79 M |
About Nanalysis Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanalysis Scientific Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanalysis Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanalysis Scientific Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It sells its products directly, as well as through a network of distributors worldwide. NANALYSIS SCIENTIFIC operates under Scientific Technical Instruments classification in the United States and is traded on OTC Exchange. It employs 107 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Nanalysis OTC Stock
Nanalysis Scientific financial ratios help investors to determine whether Nanalysis OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanalysis with respect to the benefits of owning Nanalysis Scientific security.